Please assess the completion status of the following clinical trial:

Trial Title: Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Must have at least 1 biopsy-proven nonmelanoma skin cancer with a minimum diameter of 4 mm~* No tumors located on the eyelids, distal nose, cartilaginous portions of the ears, or lips~PATIENT CHARACTERISTICS:~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception~* No known hypersensitivity to aminolevulinic acid or any component of this medication~PRIOR CONCURRENT THERAPY:~* Concurrent immunosuppressive or chemotherapeutic medications allowed~* Concurrent corticosteroids (taken by mouth or large doses taken with an inhaler) allowed~* Concurrent systemic retinoids (e.g., isotretinoin, acitretin, bexarotene, alitretinoin) or vitamin A allowed~* Other concurrent medications that may affect epidermal growth and differentiation (e.g., anti-EGFR monoclonal antibodies) allowed~* No concurrent participation in another clinical trial~* No concurrent topical treatment for the target tumor or for other nonmelanoma skin cancers~* No concurrent medical therapy or radiotherapy for other cancers

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).